title: Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts.
authors.affiliation: Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Qing
authors.initials: Q
authors.lastname: Chang
authors.forename: Mark S
authors.initials: MS
authors.lastname: Chapman
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Miner
authors.forename: David W
authors.initials: DW
authors.lastname: Hedley